Skip to main content
OpenTrials
Completed

NCT Number: NCT00403832

Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients

Cataract is a common complication in uveitis patients. Cataract operations with intraocular lens implantation are difficult in these patients because of complication due to the biocompatibility of the intraocular lens. In this study, uveal and capsular biocompatibility of two widely used acrylate intraocular lenses are compared.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Ophthalmology at St.-Franziskus Hospital

Münster, 48145, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • non infectious uveitis
  • no active inflammation
  • significant visual disturbance related to lens opacification

Exclusion criteria

  • vitreous opacification
  • ocular hypertension/glaucoma

Treatment and study plan

intraocular lenses: Two foldable, acrylic, sharp edged IOLs: AcrySof™ (AcrySof SA60AT, Alcon), and Akreos adapt™ (Bausch & Lomb)

Device

Primary outcomes

  1. visual acuity

  2. cell deposits on anterior IOL surface

  3. posterior capsular opacification

Sponsors and collaborators

Lead sponsor

St. Franziskus Hospital

Other

Registry information

Official study title

Comparison of Two Different Acrylate Intraocular Lenses in Cataract Surgery in Patients With Non-infectious Uveitis

Important dates

Study start
2005
Study completion
2007
First posted
Nov 27, 2006
Registry last updated
Jul 28, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.